Myriad Genetics' Q1 Revenues Rise 22 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market on Tuesday that its first-quarter revenues increased 22 percent, and the firm more than doubled its net income. However, both figures fell short of analysts' consensus estimate.

The Salt Lake City-based molecular diagnostics firm brought in total revenues of $85.1 million for the three-month period ended Sep. 30, compared with $70 million for the first quarter of 2009. Analysts, on average, had expected revenues of $88.3 million for Q1 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.